Literature DB >> 20818913

Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.

Patrick J Hanley1, Conrad Russell Cruz, Elizabeth J Shpall, Catherine M Bollard.   

Abstract

Because of the necessary immunodepletion prior to cord blood transplantation as well as the immaturity of cord blood immune cells, recipients experience a high incidence of viral infection in addition to complications observed after hematopoietic stem cell transplantation, such as relapse and graft-versus-host disease. We describe current immunotherapeutic approaches to treating these complications, including the generation of antigen-specific T cells from cord blood, redirecting cord blood T cells using chimeric antigen receptors, and generating cord blood-derived natural killer cells and regulatory T cells.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20818913      PMCID： PMC3178185          DOI： 10.3109/14653249.2010.517518

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


  73 in total

1.  Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Authors:  Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; Tontanai Numbenjapon; Jennifer Bennitt; Daniel Kim; David Smith; George McNamara; Zaid Al-Kadhimi; Joseph Rosenthal; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

2.  In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes.

Authors:  Kyung-Duk Park; Luciana Marti; Joanne Kurtzberg; Paul Szabolcs
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

3.  Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

Authors:  Ann M Leen; G Doug Myers; Uluhan Sili; M Helen Huls; Heidi Weiss; Kathryn S Leung; George Carrum; Robert A Krance; Chung-Che Chang; Jeffrey J Molldrem; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Catherine M Bollard
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

4.  CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

Authors:  Claudia M Kowolik; Max S Topp; Sergio Gonzalez; Timothy Pfeiffer; Simon Olivares; Nancy Gonzalez; David D Smith; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

5.  Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains.

Authors:  Jinjuan Wang; Michael Jensen; Yukang Lin; Xingwei Sui; Eric Chen; Catherine G Lindgren; Brian Till; Andrew Raubitschek; Stephen J Forman; Xiaojun Qian; Scott James; Philip Greenberg; Stanley Riddell; Oliver W Press
Journal:  Hum Gene Ther       Date:  2007-08       Impact factor: 5.695

Review 6.  Cord blood transplantation in adult patients.

Authors:  W Tse; Mj Laughlin
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

7.  A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.

Authors:  Michael H Kershaw; Jennifer A Westwood; Linda L Parker; Gang Wang; Zelig Eshhar; Sharon A Mavroukakis; Donald E White; John R Wunderlich; Silvana Canevari; Linda Rogers-Freezer; Clara C Chen; James C Yang; Steven A Rosenberg; Patrick Hwu
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

8.  Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Authors:  Loredana Ruggeri; Antonella Mancusi; Marusca Capanni; Elena Urbani; Alessandra Carotti; Teresa Aloisi; Martin Stern; Daniela Pende; Katia Perruccio; Emanuela Burchielli; Fabiana Topini; Erika Bianchi; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

9.  Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma.

Authors:  Julie R Park; David L Digiusto; Marilyn Slovak; Christine Wright; Araceli Naranjo; Jamie Wagner; Hunsar B Meechoovet; Cherrilyn Bautista; Wen-Chung Chang; Julie R Ostberg; Michael C Jensen
Journal:  Mol Ther       Date:  2007-02-13       Impact factor: 11.454

Review 10.  Immune reconstitution after unrelated cord blood transplantation.

Authors:  P Szabolcs; D Niedzwiecki
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414
View more
  13 in total

Review 1.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus.

Authors:  Patrick J Hanley; Sharon Lam; Elizabeth J Shpall; Catherine M Bollard
Journal:  J Vis Exp       Date:  2012-05-07       Impact factor: 1.355

Review 3.  Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood.

Authors:  Patrick J Hanley; Catherine M Bollard; Claudio G Brunstein
Journal:  Cytotherapy       Date:  2015-01-24       Impact factor: 5.414

4.  CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.

Authors:  Patrick J Hanley; Jan J Melenhorst; Sarah Nikiforow; Phillip Scheinberg; James W Blaney; Gail Demmler-Harrison; C Russell Cruz; Sharon Lam; Robert A Krance; Kathryn S Leung; Caridad A Martinez; Hao Liu; Daniel C Douek; Helen E Heslop; Cliona M Rooney; Elizabeth J Shpall; A John Barrett; John R Rodgers; Catherine M Bollard
Journal:  Sci Transl Med       Date:  2015-04-29       Impact factor: 17.956

5.  Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Shabnum Patel; Sharon Lam; Conrad Russell Cruz; Kaylor Wright; Christina Cochran; Richard F Ambinder; Catherine M Bollard
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-22       Impact factor: 5.742

6.  Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

Authors:  Nelli Bejanyan; Claudio G Brunstein; Qing Cao; Aleksandr Lazaryan; Xianghua Luo; Julie Curtsinger; Rohtesh S Mehta; Erica Warlick; Sarah A Cooley; Bruce R Blazar; Jeffrey S Miller; Daniel Weisdorf; John E Wagner; Michael R Verneris
Journal:  Blood Adv       Date:  2018-04-24

7.  General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.

Authors:  Rima M Saliba; Katayoun Rezvani; Ann Leen; Jeffrey Jorgensen; Nina Shah; Chitra Hosing; Simrit Parmar; Betul Oran; Amanda Olson; Gabriela Rondon; Julianne Chen; Charles Martinez; Amir Hamdi; Rohtesh S Mehta; Roy F Chemaly; Ila M Saunders; Catherine M Bollard; Elizabeth J Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2015-02-20       Impact factor: 5.742

8.  Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation.

Authors:  N Bejanyan; I Vlasova-St Louis; H Mohei; Q Cao; N El Jurdi; J E Wagner; J S Miller; C G Brunstein
Journal:  Transplant Cell Ther       Date:  2020-12-21

9.  Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.

Authors:  Verónica Ramos-Mejía; Rosa Montes; Clara Bueno; Verónica Ayllón; Pedro J Real; René Rodríguez; Pablo Menendez
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

Review 10.  Controlling cytomegalovirus: helping the immune system take the lead.

Authors:  Patrick J Hanley; Catherine M Bollard
Journal:  Viruses       Date:  2014-05-27       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.